D. Margolis

First name
Middle name
Last name
Gelfand, J. M., Weinstein, R., Porter, S. B., Neimann, A. L., Berlin, J. A., & Margolis, D. J. (2005). Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. http://doi.org/10.1001/archderm.141.12.1537
Margolis, D. J., Bowe, W. P., Hoffstad, O., & Berlin, J. A. (2005). Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol. http://doi.org/10.1001/archderm.141.9.1132
Apter, A. J., Kinman, J. L., Bilker, W. B., Herlim, M., Margolis, D. J., Lautenbach, E., et al. (2006). Is there cross-reactivity between penicillins and cephalosporins?. Am J Med. http://doi.org/10.1016/j.amjmed.2005.10.052
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006). Risk of myocardial infarction in patients with psoriasis. Jama. http://doi.org/10.1001/jama.296.14.1735
Gelfand, J. M., Shin, D. B., Neimann, A. L., Wang, X., Margolis, D. J., & Troxel, A. B. (2006). The risk of lymphoma in patients with psoriasis. J Invest Dermatol. http://doi.org/10.1038/sj.jid.5700410
Bowe, W. P., Hoffstad, O., & Margolis, D. J. (2007). Upper respiratory tract infection in household contacts of acne patients. Dermatology. http://doi.org/10.1159/000106579
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., et al. (2007). The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. http://doi.org/10.1001/archderm.143.12.1493
Margolis, D. J., Hoffstad, O., & Isseroff, R. R. (2007). Association between the use of beta-adrenergic receptor agents and the development of venous leg ulcers. Arch Dermatol. http://doi.org/10.1001/archderm.143.10.1275
Lewis, J. D., Gelfand, J. M., Troxel, A. B., Forde, K. A., Newcomb, C., Kim, H., et al. (2008). Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol. http://doi.org/10.1111/j.1572-0241.2008.01836.x
Re, L., Carbonari, D. M., Saine, M. E., Newcomb, C. W., Roy, J. A., Liu, Q., et al. (2017). Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2017-000400